Evidence map›Paper›PMID 28522553›Full record

ArticleBioscience reports2017

Glioblastoma-derived cells

Monika Witusik-Perkowska, Magdalena Zakrzewska, Beata Sikorska, Wielislaw Papierz, Dariusz J Jaskolski, Janusz Szemraj, Pawel P Liberski

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioscience reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. AInternational journal of molecular sciences · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. EGFRJournal of oncology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Monika Witusik-PerkowskaDepartment of Medical Biochemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland monika.witusik-perkowska@umed.lodz.pl.
Magdalena ZakrzewskaDepartment of Molecular Pathology and Neuropathology, Medical University of Lodz, Czechoslowacka 8/10, 92-216 Lodz, Poland.
Beata SikorskaDepartment of Molecular Pathology and Neuropathology, Medical University of Lodz, Czechoslowacka 8/10, 92-216 Lodz, Poland.
Wielislaw PapierzDepartment of Pathomorphology, Medical University of Lodz, Czechoslowacka 8/10, 92-216 Lodz, Poland.
Dariusz J JaskolskiDepartment of Neurosurgery and Oncology of Central Nervous System, Medical University of Lodz, Barlicki University Hospital, Kopcińskiego 22, Lodz 90-153, Poland.
Janusz SzemrajDepartment of Medical Biochemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
Pawel P LiberskiDepartment of Molecular Pathology and Neuropathology, Medical University of Lodz, Czechoslowacka 8/10, 92-216 Lodz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to cancer drugs is a complex phenomenon which could be influenced by

Indexed as

Antineoplastic AgentsApoptosisAutophagyBrain NeoplasmsCell CycleCell SurvivalCulture Media, Serum-FreeDacarbazineDrug Resistance, NeoplasmEpithelial-Mesenchymal TransitionGene Expression ProfilingGlioblastomaHumansNeoplasm InvasivenessPrimary Cell CultureStatistics, NonparametricAntineoplastic AgentsCulture Media, Serum-FreeDacarbazineTamoxifenTemozolomideapoptosisautophagycancer drug resistancecancer stem cellscell cultureepithelial-to-mesenchymal transitionglioblastoma

Identifiers

PMID28522553
PMCPMC5964726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.